中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
16期
25-27,28
,共4页
β受体阻滞剂%血管紧张素受体拮抗剂%钙离子拮抗剂
β受體阻滯劑%血管緊張素受體拮抗劑%鈣離子拮抗劑
β수체조체제%혈관긴장소수체길항제%개리자길항제
Beta blockers%Angiotensin receptor blockers%Calcium antagonists
目的:比较β受体阻滞剂分别联合血管紧张素受体拮抗剂(ARB)和钙离子拮抗剂(CCB)治疗江门地区中青年高血压的治疗效果。方法:选取2012年12月-2014年12月收治的江门地区中青年高血压患者300例,随机数字表法分为观察组和对照组各150例。观察组患者给予ARB联合β受体阻滞剂治疗,对照组给予CCB联合β受体阻滞剂治疗,观察两组治疗前后的血压、心率变化情况以及降压疗效和症状改变情况。结果:治疗8周后两组患者的血压、心率均较治疗前下降(P<0.05);观察组血压下降与对照组比较差异无统计学意义(P>0.05),观察组心率下降较对照组明显,差异有统计学意义(P<0.05)。在降压疗效方面,观察组总有效率为94.67%,高于对照组的82.00%,差异有统计学意义(P<0.05)。在症状改善方面,观察组总有效率为96.67%,高于对照组的84.67%,差异有统计学意义(P<0.05)。结论:β受体阻滞剂联合ARB能有效降低患者的舒张压和收缩压,减慢心率,且降压效果和症状改善显著,临床上值得推广使用。
目的:比較β受體阻滯劑分彆聯閤血管緊張素受體拮抗劑(ARB)和鈣離子拮抗劑(CCB)治療江門地區中青年高血壓的治療效果。方法:選取2012年12月-2014年12月收治的江門地區中青年高血壓患者300例,隨機數字錶法分為觀察組和對照組各150例。觀察組患者給予ARB聯閤β受體阻滯劑治療,對照組給予CCB聯閤β受體阻滯劑治療,觀察兩組治療前後的血壓、心率變化情況以及降壓療效和癥狀改變情況。結果:治療8週後兩組患者的血壓、心率均較治療前下降(P<0.05);觀察組血壓下降與對照組比較差異無統計學意義(P>0.05),觀察組心率下降較對照組明顯,差異有統計學意義(P<0.05)。在降壓療效方麵,觀察組總有效率為94.67%,高于對照組的82.00%,差異有統計學意義(P<0.05)。在癥狀改善方麵,觀察組總有效率為96.67%,高于對照組的84.67%,差異有統計學意義(P<0.05)。結論:β受體阻滯劑聯閤ARB能有效降低患者的舒張壓和收縮壓,減慢心率,且降壓效果和癥狀改善顯著,臨床上值得推廣使用。
목적:비교β수체조체제분별연합혈관긴장소수체길항제(ARB)화개리자길항제(CCB)치료강문지구중청년고혈압적치료효과。방법:선취2012년12월-2014년12월수치적강문지구중청년고혈압환자300례,수궤수자표법분위관찰조화대조조각150례。관찰조환자급여ARB연합β수체조체제치료,대조조급여CCB연합β수체조체제치료,관찰량조치료전후적혈압、심솔변화정황이급강압료효화증상개변정황。결과:치료8주후량조환자적혈압、심솔균교치료전하강(P<0.05);관찰조혈압하강여대조조비교차이무통계학의의(P>0.05),관찰조심솔하강교대조조명현,차이유통계학의의(P<0.05)。재강압료효방면,관찰조총유효솔위94.67%,고우대조조적82.00%,차이유통계학의의(P<0.05)。재증상개선방면,관찰조총유효솔위96.67%,고우대조조적84.67%,차이유통계학의의(P<0.05)。결론:β수체조체제연합ARB능유효강저환자적서장압화수축압,감만심솔,차강압효과화증상개선현저,림상상치득추엄사용。
Objective:To compare treatment effect of beta-blockers respectively joint angiotensin receptor blockers (ARB) and calcium channel blockers (CCB) in the treatment of middle-aged and young high blood pressure in Jiangmen.Method:300 young and middle-aged patients with high blood pressure from December 2012 to December 2014 were selected,according to random number table method was divided into observation group and control group,each for 150 patients.Observation group patients were given ARB joint beta blockers,the control group were given CCB joint beta-blockers,before and after treatment of blood pressure,heart rate,and antihypertensive effects and the changes of symptoms,change the situation of two groups were observed.Result:Two groups of patients’ blood pressure,heart after 8 weeks rate down significantly compared with before treatment (P<0.05); blood pressure drop in treatment group and control group,there was no statistically significant difference (P>0.05),heart rate decline in treatment group and control group,the difference was statistically significant(P<0.05).In terms of hypertension treatment,observation group total effective rate was 94.67%,control group total effective rate was 82.00%, total effective rate of observation group was obviously higher than that of control group,the difference was statistically significant (P<0.05).In terms of symptom improvement,observation group total effective rate was 96.67%,control group total effective rate was 84.67%,total effective observation group was obviously higher than that of control group,the difference was statistically significant(P<0.05).Conclusion:The application of combined beta-blockers ARB can significantly reduce the diastolic and systolic blood pressure of patients,slow heart rate,and in terms of antihypertensive effects and symptoms improve curative effect is good,worthy of clinical promotion.